NCT07099443View on ClinicalTrials.gov

Determinants of the Response to BTK Degraders (BTKd) in Double Refractory CLL

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 15, 2025

Study Completion Date

September 15, 2039

Conditions
Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia
Interventions
OTHER

Non-Interventional Sample Collection and Analysis

This study is observational. Biological samples are collected as part of standard care or for research purposes and analyzed to characterize resistance mechanisms. No treatment or intervention is administered as part of the study protocol.

Trial Locations (1)

Unknown

University Hospital, Nantes

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT07099443 - Determinants of the Response to BTK Degraders (BTKd) in Double Refractory CLL | Biotech Hunter | Biotech Hunter